These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 32647049)

  • 1. Arterial Stiffness Predicts Mortality in Individuals With Type 1 Diabetes.
    Tynjälä A; Forsblom C; Harjutsalo V; Groop PH; Gordin D;
    Diabetes Care; 2020 Sep; 43(9):2266-2271. PubMed ID: 32647049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central hemodynamics are associated with cardiovascular disease and albuminuria in type 1 diabetes.
    Theilade S; Hansen TW; Rossing P
    Am J Hypertens; 2014 Sep; 27(9):1152-9. PubMed ID: 24627444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes.
    Rotbain Curovic V; Theilade S; Winther SA; Tofte N; Eugen-Olsen J; Persson F; Hansen TW; Jeppesen J; Rossing P
    Diabetes Care; 2019 Jun; 42(6):1112-1119. PubMed ID: 30885954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arterial stiffness as a risk factor for cardiovascular events and all-cause mortality in people with Type 2 diabetes.
    Sharif S; Visseren FLJ; Spiering W; de Jong PA; Bots ML; Westerink J;
    Diabet Med; 2019 Sep; 36(9):1125-1132. PubMed ID: 30920676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopontin is a strong predictor of incipient diabetic nephropathy, cardiovascular disease, and all-cause mortality in patients with type 1 diabetes.
    Gordin D; Forsblom C; Panduru NM; Thomas MC; Bjerre M; Soro-Paavonen A; Tolonen N; Sandholm N; Flyvbjerg A; Harjutsalo V; Groop PH;
    Diabetes Care; 2014 Sep; 37(9):2593-600. PubMed ID: 24969575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study.
    Mukai H; Svedberg O; Lindholm B; Dai L; Heimbürger O; Barany P; Anderstam B; Stenvinkel P; Qureshi AR
    Nephrol Dial Transplant; 2019 Mar; 34(3):442-448. PubMed ID: 29378035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carotid-Femoral Pulse Wave Velocity as a Risk Marker for Development of Complications in Type 1 Diabetes Mellitus.
    Tougaard NH; Theilade S; Winther SA; Tofte N; Ahluwalia TS; Hansen TW; Rossing P; Frimodt-Møller M
    J Am Heart Assoc; 2020 Oct; 9(19):e017165. PubMed ID: 32955366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arterial stiffness and endothelial dysfunction independently and synergistically predict cardiovascular and renal outcome in patients with type 1 diabetes.
    Theilade S; Lajer M; Jorsal A; Tarnow L; Parving HH; Rossing P
    Diabet Med; 2012 Aug; 29(8):990-4. PubMed ID: 22414297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes.
    Pilemann-Lyberg S; Hansen TW; Tofte N; Winther SA; Theilade S; Ahluwalia TS; Rossing P
    Diabetes Care; 2019 Jun; 42(6):1088-1094. PubMed ID: 30885950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between ABO blood groups and cardiovascular disease in type 1 diabetes according to diabetic nephropathy status.
    Parente EB; Harjutsalo V; Lehto M; Forsblom C; Sandholm N; Groop PH;
    Cardiovasc Diabetol; 2020 May; 19(1):68. PubMed ID: 32429911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
    Galsgaard J; Persson F; Hansen TW; Jorsal A; Tarnow L; Parving HH; Rossing P
    Kidney Int; 2017 Nov; 92(5):1242-1248. PubMed ID: 28712855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial stiffness and vascular complications in patients with type 1 diabetes: the Finnish Diabetic Nephropathy (FinnDiane) Study.
    Gordin D; Wadén J; Forsblom C; Thorn LM; Rosengård-Bärlund M; Heikkilä O; Saraheimo M; Tolonen N; Hietala K; Soro-Paavonen A; Salovaara L; Mäkinen VP; Peltola T; Bernardi L; Groop PH;
    Ann Med; 2012 Mar; 44(2):196-204. PubMed ID: 21047152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albuminuric and non-albuminuric chronic kidney disease in type 1 diabetes: Association with major vascular outcomes risk and all-cause mortality.
    Garofolo M; Russo E; Miccoli R; Lucchesi D; Giusti L; Sancho-Bornez V; Daniele G; Del Prato S; Penno G
    J Diabetes Complications; 2018 Jun; 32(6):550-557. PubMed ID: 29705091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Rapid Kidney Function Decline, All-Cause Mortality, and Major Cardiovascular Events in Nonalbuminuric Chronic Kidney Disease in Type 2 Diabetes.
    Buyadaa O; Magliano DJ; Salim A; Koye DN; Shaw JE
    Diabetes Care; 2020 Jan; 43(1):122-129. PubMed ID: 31796570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study.
    Peeters SA; Engelen L; Buijs J; Jorsal A; Parving HH; Tarnow L; Rossing P; Schalkwijk CG; Stehouwer CDA
    Cardiovasc Diabetol; 2017 Apr; 16(1):55. PubMed ID: 28446168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Association of Severe Diabetic Retinopathy With Cardiovascular Outcomes in Long-standing Type 1 Diabetes: A Longitudinal Follow-up.
    Pongrac Barlovic D; Harjutsalo V; Gordin D; Kallio M; Forsblom C; King G; Groop PH;
    Diabetes Care; 2018 Dec; 41(12):2487-2494. PubMed ID: 30257963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study.
    Nin JW; Jorsal A; Ferreira I; Schalkwijk CG; Prins MH; Parving HH; Tarnow L; Rossing P; Stehouwer CD
    Diabetes Care; 2011 Feb; 34(2):442-7. PubMed ID: 21270199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes.
    Groop PH; Thomas MC; Moran JL; Wadèn J; Thorn LM; Mäkinen VP; Rosengård-Bärlund M; Saraheimo M; Hietala K; Heikkilä O; Forsblom C;
    Diabetes; 2009 Jul; 58(7):1651-8. PubMed ID: 19401416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.
    Lajer M; Tarnow L; Jorsal A; Teerlink T; Parving HH; Rossing P
    Diabetes Care; 2008 Apr; 31(4):747-52. PubMed ID: 18162497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes.
    Winther SA; Øllgaard JC; Tofte N; Tarnow L; Wang Z; Ahluwalia TS; Jorsal A; Theilade S; Parving HH; Hansen TW; Hazen SL; Pedersen O; Rossing P
    Diabetes Care; 2019 Aug; 42(8):1512-1520. PubMed ID: 31123156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.